¼¼°èÀÇ ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå º¸°í¼­(2025³â)
High End Cellomics Global Market Report 2025
»óǰÄÚµå : 1760551
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,217,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,987,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,756,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̸ç 2029³â±îÁö 8.4%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü·Î 43¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ¼¼Æ÷ ºÐ¼®¿¡¼­ AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, 3D ¼¼Æ÷¹è¾ç ¸ðµ¨ÀÇ Ã¤Åà Ȯ´ë, ÀÚµ¿È­ ¹× °í󸮷® ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Àç»ýÀÇÇÐ ¹× À¯ÀüÀÚ Ä¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡, ÇコÄɾî ÀÎÇÁ¶ó°¡ °³¼±µÇ´Â ½ÅÈï ½ÃÀåÀ¸·ÎÀÇ ÁøÃ⠵ ±âÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â AI¸¦ Ȱ¿ëÇÑ À̹ÌÁö ºÐ¼®, °íÇÔ·® ½ºÅ©¸®´×°ú CRISPR ±â¼úÀÇ ÅëÇÕ, 3D ¼¼Æ÷¹è¾ç ¹× ¿À°¡³ëÀÌµå ¸ðµ¨ °³¹ß, ¼¼Æ÷ ±â¹Ý ºÐ¼®ÀÇ ÀÚµ¿È­ ¹× ¼ÒÇüÈ­, Ŭ¶ó¿ìµå ±â¹Ý µ¥ÀÌÅÍ °ü¸® ¹× ºÐ¼® Ç÷§Æû µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù.

Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀå È®´ë¸¦ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤¹ÐÀÇ·á´Â À¯ÀüÀû üÁú, »ýȰ½À°ü, ȯ°æ µî¿¡ µû¶ó ȯÀÚ °³°³ÀÎÀÇ Ä¡·á¹ýÀ» ¸ÂÃãÈ­ÇÏ´Â Ä¡·á Á¢±Ù¹ýÀÔ´Ï´Ù. Á¤¹ÐÀÇ·áÀÇ ±Þ°ÝÇÑ Áõ°¡´Â À¯ÀüüÇÐÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î º¸´Ù È¿°úÀûÀÌ°í ºÎÀÛ¿ëÀÌ ÀûÀº ¸ÂÃãÇü Ä¡·á°¡ °¡´ÉÇØÁ³½À´Ï´Ù. ÇÏÀÌ¿£µå ¼¿·Î¹Í½º´Â ÷´Ü À̹Ì¡ ±â¼úÀ» ÅëÇØ ¼¼Æ÷ÀÇ °Åµ¿À» ½Ç½Ã°£À¸·Î ÆÄ¾ÇÇÏ¿© ¹ÙÀÌ¿À¸¶Ä¿¸¦ ½Äº°Çϰí Áúº´ ÁøÇàÀ» ÃßÀûÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. À̸¦ ÅëÇØ ¸ÂÃãÇü Ä¡·á °èȹÀ» Á¤±³È­Çϰí Áø´Ü Á¤È®µµ¸¦ ³ô¿© Á¤¹Ð ÀǷḦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 2¿ù, ¹Ì±¹¿¡ º»»ç¸¦ µÐ ÇコÄÉ¾î ´ÜüÀÎ °³ÀÎÈ­µÈ ÀÇÇÐ ¿¬ÇÕ(Personalized Medicine Coalition)Àº 2023³â FDA°¡ ½ÂÀÎÇÑ Èñ±Í Áúȯ¿¡ ´ëÇÑ °³ÀÎÈ­µÈ Ä¡·áÁ¦´Â 16Á¾À¸·Î 2022³â 6Á¾¿¡ ºÒ°úÇß´ø °Í¿¡ ºñÇØ Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ±× °á°ú, Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

ÇÏÀÌ¿£µå ¼¿·Î¹Í½º ½ÃÀåÀÇ ±â¾÷µéÀº »ó¼¼ÇÑ Ç¥ÇöÇü ºÐ¼®À¸·Î Á¤¹ÐÀÇ·á¿Í ½Å¾à°³¹ßÀ» Áö¿øÇÏ´Â °íÇÔ·® ºÐ¼® ½Ã½ºÅÛ µîÀÇ Á¦Ç° ¹ßÀü¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. °íÇÔ·® ºÐ¼®(HCA) ½Ã½ºÅÛÀº °í󸮷® ȯ°æ¿¡¼­ ¿©·¯ ¼¼Æ÷ ÆÄ¶ó¹ÌÅ͸¦ µ¿½Ã¿¡ ÃøÁ¤ÇÒ ¼ö Àִ ÷´Ü À̹Ì¡ ÅøÀÔ´Ï´Ù. º¹ÀâÇÑ »ý¹°ÇÐÀû °úÁ¤À» ¼¼Æ÷ ¼öÁØ¿¡¼­ ºÐ¼®ÇÒ ¼ö ÀÖ¾î ½Å¾à°³¹ß, µ¶¼º ½ÃÇè, ¸ÂÃãÀÇ·á¿¡ ±ÍÁßÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 2¿ù, Àü±â°øÇÐ ¹× ¼ÒÇÁÆ®¿þ¾î Àü¹® ±â¾÷ÀÎ ÀϺ»ÀÇ ¿äÄÚ°¡¿Í Àü±â ÁÖ½Äȸ»ç´Â CellVoyager CQ3000À» Ãâ½ÃÇÏ¿´½À´Ï´Ù. ÀÌ º¥Ä¡Å¾Çü °íÇÔ·® ºÐ¼® ½Ã½ºÅÛÀº »ý¼¼Æ÷¹è¾çÀÇ °íÈ­Áú 3D À̹ÌÁö¸¦ ½Å¼ÓÇÏ°Ô È¹µæÇÏ¿© ¼¼Æ÷ ¹ÝÀÀ°ú ¾àÈ¿¸¦ »ó¼¼Çϰí È¿À²ÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±¤µ¶¼ºÀ» ÃÖ¼ÒÈ­ÇÏ´Â µà¾ó ½ºÇÇ´× µð½ºÅ© ±â¼úÀ» äÅÃÇÑ ¿ä²¿°¡¿ÍÀü±â µ¶ÀÚÀûÀÎ °øÃÊÁ¡ ½ºÄ³³Ê À¯´Ö, ¾ÈÁ¤ÀûÀ̰í Àå½Ã°£ÀÇ ¶óÀÌºê ¼¿ À̹Ì¡À» °¡´ÉÇÏ°Ô ÇÏ´Â °íÁ¤¹Ð ¿Âµµ Á¦¾î, µö·¯´× ºÐ¼®¿ë ¿É¼Ç µîÀ» žÀçÇϰí ÀÖ½À´Ï´Ù. À̹ÌÁö ºÐ¼® ¼ÒÇÁÆ®¿þ¾î CellPathfinder¿Í °áÇÕÇÏ¿© °íµµÀÇ µ¥ÀÌÅÍ ºÐ¼®ÀÌ °¡´ÉÇÏ¿©, ½Å¾à°³¹ß ¿¬±¸, Àç»ýÀÇ·á ¿¬±¸, ±âÃÊ»ý¹°ÇÐ ¿¬±¸¸¦ Áö¿øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

High-end cellomics involves state-of-the-art, automated technologies that combine high-content imaging with advanced data analytics to study cellular behavior at the single-cell level. These platforms facilitate high-throughput screening and deliver quantitative insights into cell morphology, molecular expression, and functional responses. They are particularly effective for identifying subtle cellular changes in response to drugs or environmental factors.

The primary product types in high-end cellomics include instruments, reagents and consumables, and software and services. Instruments are sophisticated scientific tools designed for precise measurement, imaging, and analysis of cells, tissues, and biological samples in both research and clinical applications. These tools incorporate various technologies such as microscopy, flow cytometry, single-cell genomics, mass spectrometry, next-generation sequencing, and more, serving a range of applications such as drug discovery, cancer research, neuroscience, stem cell research, regenerative medicine, personalized medicine, and others. They are utilized by diverse end-users, including biotechnology and pharmaceutical companies, hospitals and diagnostic laboratories, contract research organizations, and more.

The high end cellomics market research report is one of a series of new reports from The Business Research Company that provides high end cellomics market statistics, including the high end cellomics industry global market size, regional shares, competitors with the high end cellomics market share, detailed high end cellomics market segments, market trends, opportunities, and any further data you may need to thrive in the high end cellomics industry. This high end cellomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The high-end cellomics market size has grown strongly in recent years. It will grow from $2.90 billion in 2024 to $3.15 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth during the historic period can be attributed to the increasing demand for high-content screening in drug discovery, technological advancements in imaging systems, growth in personalized medicine research, rising investments in academic and pharmaceutical research and development, and the expansion of stem cell and cancer research applications.

The high-end cellomics market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth during the forecast period is expected to result from the integration of AI and machine learning in cell analysis, the growing adoption of 3D cell culture models, the rising demand for automated and high-throughput systems, the increasing focus on regenerative medicine and gene therapy, and the expansion into emerging markets with improving healthcare infrastructure. Major trends during the forecast period include AI-driven image analysis, the integration of high-content screening with CRISPR technologies, the development of 3D cell culture and organoid models, automation and miniaturization of cell-based assays, and cloud-based data management and analytics platforms.

The growing demand for precision medicine is expected to drive the expansion of the high-end cellomics market. Precision medicine is an approach to treatment that customizes therapies for individual patients based on their genetic makeup, lifestyle, and environment. The surge in precision medicine is fueled by advancements in genomics, allowing for personalized treatments that are more effective and have fewer side effects. High-end cellomics uses advanced imaging technologies to provide real-time insights into cellular behavior, helping identify biomarkers and track disease progression. This improves precision medicine by refining personalized treatment plans and enhancing diagnostic accuracy. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based healthcare organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare diseases, up from just six in 2022. As a result, the rising demand for precision medicine is driving growth in the high-end cellomics market.

Companies in the high-end cellomics market are focused on advancing products such as high-content analysis systems to support precision medicine and drug discovery with detailed phenotypic analysis. A high-content analysis (HCA) system is an advanced imaging tool that can simultaneously measure multiple cellular parameters in high-throughput environments. It allows for the analysis of complex biological processes at the cellular level, providing valuable data for drug discovery, toxicity testing, and personalized medicine. For example, in February 2024, Yokogawa Electric Corporation, a Japan-based company specializing in electrical engineering and software, launched the CellVoyager CQ3000. This benchtop high-content analysis system captures high-definition 3D images of live cell cultures quickly, allowing for detailed and efficient evaluation of cellular reactions and drug effects. It features Yokogawa's proprietary confocal scanner unit with dual spinning-disk technology to minimize phototoxicity, high-precision temperature control for stable long-term live cell imaging, and options for deep learning analysis. When combined with the CellPathfinder image analysis software, it facilitates advanced data analysis, supporting drug discovery, regenerative medicine research, and basic biological studies.

In January 2023, Bruker Corporation, a U.S.-based provider of advanced fluorescence microscopy imaging products, acquired ACQUIFER Imaging GmbH for an undisclosed sum. This acquisition strengthens Bruker's bioimaging portfolio by integrating ACQUIFER's flagship HIVE data management systems, which offer high-performance computing, deep learning, and scalable data storage solutions. ACQUIFER Imaging GmbH, based in Germany, specializes in big-data management solutions for bioimaging and high-content microscopy.

Major players in the high end cellomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company (BD), GE Healthcare, Agilent Technologies Inc., Sartorius AG, Bio-Rad Laboratories, Yokogawa Electric Corporation, Bruker Corporation, Carl Zeiss AG, Miltenyi Biotec GmbH, Leica Microsystems GmbH, 10x Genomics, Promega Corporation, Abcam plc, Molecular Devices LLC, NanoString Technologies, Sphere Fluidics, Nikon Instruments Inc., and Tecan Group Ltd.

North America was the largest region in the high-end cellomics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in high-end cellomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the high-end cellomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The high-end cellomics market consists of revenues earned by entities by providing services such as single-cell analysis, target identification and validation, and customization. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-end cellomics market also includes sales of assay kits, cell imaging plates, live-cell imaging chambers, and artificial intelligence (AI)-based analytics modules. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified.)

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

High End Cellomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on high end cellomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for high end cellomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The high end cellomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. High End Cellomics Market Characteristics

3. High End Cellomics Market Trends And Strategies

4. High End Cellomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global High End Cellomics Growth Analysis And Strategic Analysis Framework

6. High End Cellomics Market Segmentation

7. High End Cellomics Market Regional And Country Analysis

8. Asia-Pacific High End Cellomics Market

9. China High End Cellomics Market

10. India High End Cellomics Market

11. Japan High End Cellomics Market

12. Australia High End Cellomics Market

13. Indonesia High End Cellomics Market

14. South Korea High End Cellomics Market

15. Western Europe High End Cellomics Market

16. UK High End Cellomics Market

17. Germany High End Cellomics Market

18. France High End Cellomics Market

19. Italy High End Cellomics Market

20. Spain High End Cellomics Market

21. Eastern Europe High End Cellomics Market

22. Russia High End Cellomics Market

23. North America High End Cellomics Market

24. USA High End Cellomics Market

25. Canada High End Cellomics Market

26. South America High End Cellomics Market

27. Brazil High End Cellomics Market

28. Middle East High End Cellomics Market

29. Africa High End Cellomics Market

30. High End Cellomics Market Competitive Landscape And Company Profiles

31. High End Cellomics Market Other Major And Innovative Companies

32. Global High End Cellomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The High End Cellomics Market

34. Recent Developments In The High End Cellomics Market

35. High End Cellomics Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â